| Satya S Thippareddi, MD | |
|
55 Carlton St, Athens, GA 30602-4586 | |
| (706) 542-8638 | |
| (706) 542-8621 |
| Full Name | Satya S Thippareddi |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 55 Carlton St, Athens, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174537567 | NPI | - | NPPES |
| 47055301100 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | TEP4863 (Nebraska) | Primary |
| Entity Name | Clarinda Regional Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629196241 PECOS PAC ID: 4587573993 Enrollment ID: O20031205000207 |
News Archive
In a study published in the Proceedings of the National Academy of Sciences (PNAS) on Aug. 6, an international team led by Igor Roninson, of the University of South Carolina and the Medical University of South Carolina, reported the development of a new class of drugs that may prove useful in the treatment of cancer and aging-associated disorders.
Prompted by an inquiry from GlobalPost, U.S. officials have said the Obama administration called for a $550 million reduction - an 11 percent cut - for its global AIDS program in its FY 2013 budget request because the "government didn't need more money because there has been nearly $1.5 billion stuck in the pipeline for 18 months or more," GlobalPost reports.
PharmAbcine, a specialized biotech company focused on the development of fully-human monoclonal antibodies for the treatment of cancer and inflammatory diseases, announced that is has received $6 million USD in a Series A financing. OrbiMed's Caduceus Asia Partners and Novartis Korea Venture Fund co-led the round, with additional participation from an international syndicate including Green Cross, Tong Yang and Saehan Venture Fund.
Human cells have an intrinsic capacity to destroy HIV. However, the virus has evolved to contain a gene that blocks this ability. When this gene is removed from the virus, the innate human immune system destroys HIV by mutating it to the point where it can no longer survive.
From the time presidential candidate Theodore Roosevelt first discussed health care reform in 1912, the topic has been a precedent-setting issue in the U.S. The 2010 passage of health care legislation is no different, but has many Americans in a quandary about how it will affect them. This is especially true of senior citizens.
› Verified 4 days ago
| Entity Name | Shenandoah Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497810972 PECOS PAC ID: 9436063237 Enrollment ID: O20040209000347 |
News Archive
In a study published in the Proceedings of the National Academy of Sciences (PNAS) on Aug. 6, an international team led by Igor Roninson, of the University of South Carolina and the Medical University of South Carolina, reported the development of a new class of drugs that may prove useful in the treatment of cancer and aging-associated disorders.
Prompted by an inquiry from GlobalPost, U.S. officials have said the Obama administration called for a $550 million reduction - an 11 percent cut - for its global AIDS program in its FY 2013 budget request because the "government didn't need more money because there has been nearly $1.5 billion stuck in the pipeline for 18 months or more," GlobalPost reports.
PharmAbcine, a specialized biotech company focused on the development of fully-human monoclonal antibodies for the treatment of cancer and inflammatory diseases, announced that is has received $6 million USD in a Series A financing. OrbiMed's Caduceus Asia Partners and Novartis Korea Venture Fund co-led the round, with additional participation from an international syndicate including Green Cross, Tong Yang and Saehan Venture Fund.
Human cells have an intrinsic capacity to destroy HIV. However, the virus has evolved to contain a gene that blocks this ability. When this gene is removed from the virus, the innate human immune system destroys HIV by mutating it to the point where it can no longer survive.
From the time presidential candidate Theodore Roosevelt first discussed health care reform in 1912, the topic has been a precedent-setting issue in the U.S. The 2010 passage of health care legislation is no different, but has many Americans in a quandary about how it will affect them. This is especially true of senior citizens.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Satya S Thippareddi, MD 55 Carlton St, Athens, GA 30602-1503 Ph: (706) 542-8638 | Satya S Thippareddi, MD 55 Carlton St, Athens, GA 30602-4586 Ph: (706) 542-8638 |
News Archive
In a study published in the Proceedings of the National Academy of Sciences (PNAS) on Aug. 6, an international team led by Igor Roninson, of the University of South Carolina and the Medical University of South Carolina, reported the development of a new class of drugs that may prove useful in the treatment of cancer and aging-associated disorders.
Prompted by an inquiry from GlobalPost, U.S. officials have said the Obama administration called for a $550 million reduction - an 11 percent cut - for its global AIDS program in its FY 2013 budget request because the "government didn't need more money because there has been nearly $1.5 billion stuck in the pipeline for 18 months or more," GlobalPost reports.
PharmAbcine, a specialized biotech company focused on the development of fully-human monoclonal antibodies for the treatment of cancer and inflammatory diseases, announced that is has received $6 million USD in a Series A financing. OrbiMed's Caduceus Asia Partners and Novartis Korea Venture Fund co-led the round, with additional participation from an international syndicate including Green Cross, Tong Yang and Saehan Venture Fund.
Human cells have an intrinsic capacity to destroy HIV. However, the virus has evolved to contain a gene that blocks this ability. When this gene is removed from the virus, the innate human immune system destroys HIV by mutating it to the point where it can no longer survive.
From the time presidential candidate Theodore Roosevelt first discussed health care reform in 1912, the topic has been a precedent-setting issue in the U.S. The 2010 passage of health care legislation is no different, but has many Americans in a quandary about how it will affect them. This is especially true of senior citizens.
› Verified 4 days ago
Dr. Ron Elliott, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 55 Carlton St, Athens, GA 30602 Phone: 706-542-8621 Fax: 706-583-0217 | |
Dr. Garth Russo, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 55 Carlton St, Athens, GA 30602 Phone: 706-542-8621 Fax: 706-583-0217 | |
Mr. Errol Duncan, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1061 Dowdy Rd, Suite 100, Athens, GA 30606 Phone: 706-621-7575 Fax: 706-621-7557 | |
Samuel C Griffin, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 700 Sunset Dr, Suite 101, Athens, GA 30606 Phone: 706-548-6068 Fax: 706-354-1218 | |
Ruth Adetoun Adene-peter, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 485 Highway 29 N, Athens, GA 30601 Phone: 706-438-4080 Fax: 706-438-4081 | |
Michael N Carter, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 892 Prince Ave, Athens, GA 30606 Phone: 706-227-2027 Fax: 706-227-2433 |